| | | |  | | | | By Lev Facher Adobe Cities and states are lobbying hard to bring ARPA-H to their backyard. But experts say it won't be the economic boon they're hoping for. Read More | | By Mario Aguilar Mike Reddy for STAT Researchers are casting a light on the lack of focus on engagement and attrition rates for apps to treat mental health conditions. Read More | | By Allison DeAngelis Courtesy IDRx On Tuesday, Borisy launched a company called IDRx that plans to combine multiple drug compounds to create precise, durable cancer treatments. Read More | | Sponsor content by Gilead Sciences Working together to end the HIV epidemic for everyone, everywhere With 35 years of experience, Gilead knows that working together is key to dismantling the many barriers to HIV care. Gilead recently launched the 'Together' campaign to champion the need for transformative, multi-stakeholder collaboration to help end the HIV epidemic for everyone, everywhere and highlight the real stories of bold innovators who are making it happen. Learn how our courageous collaborators are going beyond medicine to make a difference all over the world. | | By Joan Bregstein Stephanie Nano/AP With more and more people taking the antiviral Paxlovid to treat early Covid-19, the number of rebound Covid cases will likely increase. Read More | | By Ed Silverman Aram Boghosian for STAT The court opinion shot down arguments by unions, insurers, and the city of Baltimore, which alleged that AbbVie “abused the patent system.” Read More | | By Tara Bannow David Goldman/AP Medicare won’t stop publishing some hospital safety data next year after all. Regulators reversed course after backlash from patient safety groups. Read More | | By Victor Wang Adobe Hospitals and health systems are key to using real-world data and real-world evidence to help develop new drugs and devices. Read More | |
No comments